Observational studyBMC cancer2019
Are social inequalities in acute myeloid leukemia survival explained by differences in treatment utilization? Results from a French longitudinal observational study among older patients.
Observational study in BMC cancer, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Factors Explaining Socio-Economic Inequalities in Cancer Survival: A Systematic Review.Cancer control : journal of the Moffitt Cancer CenterPooled it
- Socioeconomic inequality in treatment of acute myeloid leukaemia (AML) in England, 2015-2022: A population-based study.British journal of haematology · 2026Article
- Stratifying survival: the role of social determinants of health on AML outcomes by ELN 2022 criteria.Blood advances · 2026Article
- Characteristics of patients diagnosed for acute myeloid leukemia before and during the 2020 COVID-19 pandemic: the DATAML population-based cohort.Scientific reports · 2026Article
- Cytogenetic Abnormalities and Their Impact on Acute Myeloid Leukemia Outcomes Following Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Center Retrospective Study.Health science reports · 2025Article
- Addressing Health Disparities in Hematologic Malignancies: from Genes to Outreach.Blood cancer discovery · 2025Review
- Impact of patient demographics on treatment outcomes in AML: a population-based registry in England, 2013-2020.Blood advances · 2024Article
- Socio-demographic determinants of myelofibrosis outcomes in an underserved center and the SEER national database.Annals of hematology · 2024Article
- Increasing access to fertility preservation for women with breast cancer: protocol for a stepped-wedge cluster randomized trial in France.BMC public health · 2024Article
- Sociodemographic associations with uptake of novel therapies for acute myeloid leukemia.Blood cancer journal · 2023Article
- Outcomes and survival predictors of Latin American older adults with acute myeloid leukemia: Data from a single center.Hematology, transfusion and cell therapy · 2023Article
- Factors influencing access to specialised haematology units during acute myeloblastic leukaemia patient care: A population-based study in France.Cancer medicine · 2023Article
- Co-management strategies for acute myeloid leukemia patients in the community setting.Frontiers in oncology · 2022Article
- Patterns of undertreatment among patients with acute myeloid leukemia (AML): considerations for patients eligible for non-intensive chemotherapy (NIC).Journal of cancer research and clinical oncology · 2021Review
- The long shadow of socioeconomic deprivation over the modern management of acute myeloid leukemia: time to unravel the challenges.Blood cancer journal · 2021Review
- Poor Survival and Differential Impact of Genetic Features of Black Patients with Acute Myeloid Leukemia.Cancer discovery · 2021Article
- Access to Therapy for Acute Myeloid Leukemia in the Developing World: Barriers and Solutions.Current oncology reports · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundEvidences support social inequalities in cancer survival. Studies on hematological malignancies, and more specifically Acute Myeloid Leukemia (AML), are sparser. Our study assessed: 1/ the influence of patients' socioeconomic position on survival, 2/ the role of treatment in this relationship, and 3/ the influence of patients' socioeconomic position on treatment utilization.
methodsThis prospective multicenter study includes all patients aged 60 and older, newly diagnosed with AML, excluding promyelocytic subtypes, between 1st January 2009 to 31st December 2014 in the South-West of France. Data came from medical files. Patients' socioeconomic position was measured by an ecological deprivation index, the European Deprivation Index. We studied first, patients' socioeconomic position influence on overall survival (n = 592), second, on the use of intensive chemotherapy (n = 592), and third, on the use of low intensive treatment versus best supportive care among patients judged unfit for intensive chemotherapy (n = 405).
resultsWe found an influence of patients' socioeconomic position on survival (highest versus lowest position HR
conclusionsFinally, these results suggest an indirect influence of patients' socioeconomic position on survival through AML initial presentation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.